CLINICAL TRIALS PROFILE FOR TREXIMET
✉ Email this page to a colleague
All Clinical Trials for TREXIMET
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00240617 ↗ | Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | Completed | GlaxoSmithKline | Phase 3 | 2005-10-01 | The purpose of this study is to determine the consistency of response for Treximet (formerly known as Trexima) when treating four acute migraine attacks at the mild pain phase and within 1 hour of onset of head pain. |
| NCT00240630 ↗ | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | Completed | GlaxoSmithKline | Phase 3 | 2005-10-01 | The purpose of this study is to determine the consistency of response for Treximet (sumatriptan/naproxen sodium), formerly known as Trexima, when treating four acute migraine attacks at the mild pain phase and within 1 hour of onset of head pain. |
| NCT00329355 ↗ | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) | Completed | GlaxoSmithKline | Phase 3 | 2006-05-01 | This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine. |
| NCT00329459 ↗ | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea | Completed | GlaxoSmithKline | Phase 3 | 2006-05-01 | This study was designed to determine efficacy of TREXIMA compared to placebo for the treatment of a menstrual migraine. |
| NCT00387881 ↗ | TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) | Completed | GlaxoSmithKline | Phase 3 | 2006-09-01 | This study was designed to determine the efficacy and tolerability of TREXIMET (formerly known as TREXIMA) compared to placebo for the acute treatment of probable migraine, a sub-type of migraine. |
| NCT00488514 ↗ | Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents | Completed | GlaxoSmithKline | Phase 3 | 2007-07-13 | This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine. |
| NCT00573170 ↗ | TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults | Completed | GlaxoSmithKline | Phase 3 | 2008-02-01 | Study TRX109011/TRX109013, A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) versus Butalbital-containing Combination Medications (BCM) for the Acute Treatment of Migraine when administered during the Moderate-Severe Pain Phase of the Migraine (Studies 1 and 2 of 2) |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TREXIMET
Condition Name
Clinical Trial Locations for TREXIMET
Trials by Country
Clinical Trial Progress for TREXIMET
Clinical Trial Phase
Clinical Trial Sponsors for TREXIMET
Sponsor Name
